BioAtla Statistics
Total Valuation
BioAtla has a market cap or net worth of $77.95 million. The enterprise value is -$758,242.
| Market Cap | 77.95M |
| Enterprise Value | -758,242 |
Important Dates
The next estimated earnings date is Tuesday, August 6, 2024, after market close.
| Earnings Date | Aug 6, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
BioAtla has 48.12 million shares outstanding. The number of shares has increased by 1.07% in one year.
| Shares Outstanding | 48.12M |
| Shares Change (YoY) | +1.07% |
| Shares Change (QoQ) | +0.21% |
| Owned by Insiders (%) | 10.82% |
| Owned by Institutions (%) | 61.12% |
| Float | 35.85M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.57 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.49, with a Debt / Equity ratio of 0.04.
| Current Ratio | 4.49 |
| Quick Ratio | n/a |
| Debt / Equity | 0.04 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -140.40% and return on invested capital (ROIC) is -242.47%.
| Return on Equity (ROE) | -140.40% |
| Return on Assets (ROA) | -88.30% |
| Return on Capital (ROIC) | -242.47% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.83M |
| Employee Count | 65 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -44.06% in the last 52 weeks. The beta is 1.04, so BioAtla's price volatility has been similar to the market average.
| Beta (5Y) | 1.04 |
| 52-Week Price Change | -44.06% |
| 50-Day Moving Average | 1.71 |
| 200-Day Moving Average | 2.16 |
| Relative Strength Index (RSI) | 48.33 |
| Average Volume (20 Days) | 1,117,122 |
Short Selling Information
The latest short interest is 3.98 million, so 8.27% of the outstanding shares have been sold short.
| Short Interest | 3.98M |
| Short Previous Month | 5.25M |
| Short % of Shares Out | 8.27% |
| Short % of Float | 11.09% |
| Short Ratio (days to cover) | 3.96 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -125.21M |
| Pretax Income | -119.24M |
| Net Income | -119.24M |
| EBITDA | -118.07M |
| EBIT | -119.24M |
| Earnings Per Share (EPS) | -$2.49 |
Balance Sheet
The company has $80.63 million in cash and $1.92 million in debt, giving a net cash position of $78.71 million or $1.64 per share.
| Cash & Cash Equivalents | 80.63M |
| Total Debt | 1.92M |
| Net Cash | 78.71M |
| Net Cash Per Share | $1.64 |
| Equity (Book Value) | 49.72M |
| Book Value Per Share | 1.03 |
| Working Capital | 67.17M |
Cash Flow
In the last 12 months, operating cash flow was -$112.19 million and capital expenditures -$48,000, giving a free cash flow of -$112.24 million.
| Operating Cash Flow | -112.19M |
| Capital Expenditures | -48,000 |
| Free Cash Flow | -112.24M |
| FCF Per Share | -$2.33 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
BioAtla does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.07% |
| Shareholder Yield | -1.07% |
| Earnings Yield | -152.97% |
| FCF Yield | -143.99% |
Analyst Forecast
The average price target for BioAtla is $12.75, which is 687.04% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $12.75 |
| Price Target Difference | 687.04% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | -32.48% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |